Can venous saturations from the central venous line and the venous side of the heart–lung machine be interchangeable with mixed venous saturation from the pulmonary artery in children undergoing open-heart surgery?

2017 ◽  
Vol 11 (3) ◽  
pp. 48
Author(s):  
SayedK Abd-Elshafy ◽  
MohamedS Ali ◽  
EssamM Abd Allah ◽  
AhmedF Ghoneim

1959 ◽  
Vol 37 (2) ◽  
pp. 184-189 ◽  
Author(s):  
William W. Musicant ◽  
Reuben R. Lewis ◽  
Belmont S. Musicant ◽  
Robert M. Anderson ◽  
Jerome Harold Kay


1964 ◽  
Vol 83 (2) ◽  
pp. 146-158 ◽  
Author(s):  
Togo Horiuchi ◽  
Kei Koyamada ◽  
Takeo Honda ◽  
Takeshi Ishitoya ◽  
Yasuhiko Sagawa ◽  
...  


Author(s):  
W. Bruce Fye

During the early 1950s, several dozen surgeons were attempting to develop technologies and techniques that would allow them to operate inside the heart. The challenge was to develop a safe way to temporarily take over the functions of the heart and lungs so the heart could be opened and drained of blood. A surgeon could then see and repair abnormal or damaged structures inside the organ. The first patients were children or adolescents with congenital heart defects that had caused heart failure. Mayo surgeon John Kirklin led a multidisciplinary team in the testing and clinical use of a heart-lung machine that had been refined in Rochester from plans provided by IBM and John Gibbon Jr. of Philadelphia. Although initial mortality was high, experience with the Mayo-Gibbon machine proved that it was possible to operate inside the hearts and save the lives of patients who were destined to die without surgery.



1984 ◽  
Vol 12 (1) ◽  
pp. 9-13 ◽  
Author(s):  
M. J. Boscoe ◽  
S. Dawling ◽  
M. A. Thompson ◽  
R. M. Jones

Thirty-six patients (29 males and 7 females) undergoing open-heart surgery received one of three different dose regimens of lorazepam. All received a weight-related oral dose (2 mg, 3 mg or 4 mg) pre-operatively for night sedation. Twenty-four patients had an additional weight-related dose (2 mg, 3 mg or 4 mg intravenously) either as part of the induction (12 patients) or just prior to connection of the heart-lung machine (12 patients). Plasma concentrations of lorazepam were measured 20 minutes after induction, immediately before bypass, 30 and 60 on bypass and 30 minutes after bypass. Only when additional intravenous lorazepam was given prior to connection to the heart-lung machine were plasma lorazepam concentrations obtained compatible with complete amnesia.





Author(s):  
M. Ertan Taskin ◽  
Tao Zhang ◽  
Bartley P. Griffith ◽  
Zhongjun J. Wu

The heart-lung machine has been commonly used to replace or supplement the functions of both the heart and lung in the open heart surgery and extracorporeal membrane oxygenation (ECMO). Although ECMO devices are efficient on respiratory support, this traditional system consists of multiple components and is bulky. Furthermore, ECMO devices are associated with clinical complications as well as the necessity of being confined to the bed. To eliminate these, we aimed to design and develop a wearable artificial pump lung (APL) device.



1974 ◽  
Vol 2 (1) ◽  
pp. 43-47 ◽  
Author(s):  
D. G. Woods ◽  
Jean Lumley ◽  
W. J. Russell ◽  
R. D. Jack

Fifty-three central venous catheters were followed up by radiography or direct observation during open-heart surgery. Forty of these were satisfactorily positioned for recording central venous pressure or for sampling central venous blood. Radiography showed that the catheter tip was in an unsatisfactory position in 21 per cent of cases. It is recommended that radiographic confirmation of the site of the catheter tip be obtained as a routine and if necessary the catheter can be re-positioned and another radiograph taken.



Sign in / Sign up

Export Citation Format

Share Document